Laboratory and Clinical Experience with Carbomycin
- 13 August 1953
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 249 (7) , 261-269
- https://doi.org/10.1056/nejm195308132490701
Abstract
CARBOMYCIN is a new antibiotic substance produced by a soil actinomycete, Streptomyces halstedii. The isolation, purification and characterization of its physical and chemical properties have been accomplished by the workers from the Pfizer Research Laboratories.1 It is a crystalline, monobasic substance containing carbon, hydrogen and nitrogen with a molecular weight of about 860. The free base is only slightly water soluble, but dissolves readily in organic solvents. Acid salts such as the hydrochloride, phosphate or sulfate are prepared readily and are water soluble. Low degrees of both acute and chronic toxicity were noted for animals, including dogs, after both . . .Keywords
This publication has 3 references indexed in Scilit:
- Laboratory and Clinical Experience with CarbomycinNew England Journal of Medicine, 1953
- Cross Resistance to Antibiotics: Effect of Exposures of Bacteria to Carbomycin or Erythromycin in VitroExperimental Biology and Medicine, 1952
- BACTERIAL SPECTRUM OF ERYTHROMYCIN, CARBOMYCIN, CHLORAMPHENICOL, AUREOMYCIN, AND TERRAMYCIN1952